Variant report
Variant | esv1815655 |
---|---|
Chromosome Location | chr4:172367540-172432296 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:214429883..214430693-chr4:172382652..172383247,2 | MCF-7 | breast: | |
2 | chr4:172410818..172412907-chr4:172427241..172429415,2 | K562 | blood: | |
3 | chr4:172410818..172412907-chr4:172427241..172429415,2 | K562 | blood: | |
4 | chr4:172406443..172409078-chr4:172410535..172412663,2 | MCF-7 | breast: | |
5 | chr4:172430767..172434419-chr4:172434504..172437331,3 | K562 | blood: | |
6 | chr4:172406443..172409078-chr4:172410535..172412663,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4692883 | chr4:172367540-172367541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190207483 | chr4:172367551-172367552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552237763 | chr4:172367562-172367563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182438772 | chr4:172367579-172367580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs17056919 | chr4:172367611-172367612 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs369181731 | chr4:172367664-172367665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs35827690 | chr4:172367717-172367718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139973560 | chr4:172367721-172367722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs574404219 | chr4:172367741-172367742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs143831474 | chr4:172367762-172367763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs4692884 | chr4:172367775-172367776 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs577160735 | chr4:172367783-172367784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs372127633 | chr4:172367795-172367796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559864082 | chr4:172367810-172367811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs573347408 | chr4:172367872-172367873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542456601 | chr4:172367875-172367876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562222189 | chr4:172367914-172367915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186617664 | chr4:172367918-172367919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146846159 | chr4:172367920-172367921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563174218 | chr4:172367923-172367924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535516623 | chr4:172367986-172367987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551862484 | chr4:172368010-172368011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs114168967 | chr4:172368016-172368017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573978227 | chr4:172368045-172368046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs191969528 | chr4:172368047-172368048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs982237 | chr4:172368067-172368068 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs17200419 | chr4:172368076-172368077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34925472 | chr4:172368157-172368158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536987914 | chr4:172368245-172368246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs181690082 | chr4:172368288-172368289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs982238 | chr4:172368294-172368295 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs185648594 | chr4:172368319-172368320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs539843099 | chr4:172368344-172368345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190410456 | chr4:172368380-172368381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182099992 | chr4:172368387-172368388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187897905 | chr4:172368408-172368409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs17056925 | chr4:172368442-172368443 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs575705529 | chr4:172368469-172368470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs78636448 | chr4:172368487-172368488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs78007950 | chr4:172368488-172368489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs77258940 | chr4:172368499-172368500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs575783380 | chr4:172368520-172368521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144306473 | chr4:172368525-172368526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs115087418 | chr4:172368537-172368538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533426439 | chr4:172368546-172368547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545795988 | chr4:172368563-172368564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558878896 | chr4:172368603-172368604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs549665254 | chr4:172368653-172368654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568883065 | chr4:172368708-172368709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs543926014 | chr4:172381418-172381419 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 22127048 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:172367400-172368800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr4:172367600-172368600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr4:172381400-172381800 | Active TSS | Fetal Heart | heart |
4 | chr4:172382400-172383000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr4:172382400-172383200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr4:172382600-172383000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
7 | chr4:172394000-172395000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr4:172404800-172405000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr4:172405000-172405800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr4:172405800-172406200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr4:172418000-172418800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |